Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Assessing patient fitness involves more than evaluating chronological age, noted Brandon Blue, MD, of the Moffitt Cancer ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Stephen Abreu has been appointed by the Board as Executive Director. He will lead the organization's overall strategy and ...

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

The NHS announced in May that it would trial personalised cancer vaccines designed by biotech giants BioNTech and Genentech.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 ...

Norwegian clinical-stage biotech Nykode Therapeutics revealed that it has received notification from Genentech, a US ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Mississippi Baptist Medical Center teamed up with Genentech to bring awareness of healthy lungs for Lung Cancer Awareness ...

ATLANTA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- SC24 -- NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source ...

Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...